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Abstract
Functional tests are commonly used for chronic kidney disease (CKD) patients undergoing
hemodialysis (HD). However, the relative and absolute reliability of such physical perfor-
mance-outcome assessments must first be determined in specific patient cohorts. The aims
of this study were to assess the relative and the absolute reliability of the Short Physical Per-
formance Battery (SPPB), One-Legged Stance Test (OLST), and Timed Up and Go (TUG)
test, as well as the minimal detectable change (MDC) scores for these tests in CKD patients
receiving HD. Seventy-one end-stage CKD patients receiving HD therapy, aged between 21
and 90 years, participated in the study. The patients completed two testing sessions one to
two weeks apart and performed by the same examiner, comprising the following tests: the
SPPB (n = 65), OLST (n = 62), and TUG test (n = 66). High intraclass correlation coefficients
(0.90) were found for all the tests, suggesting that their relative reliability is excellent. The
MDC scores for the 90% confidence intervals were as follows: 1.7 points for the SPPB, 11.3
seconds for the OLST, and 2.9 seconds for the TUG test. The reliability of the SPPB, OLST,
and TUG test for this sample were all considered to be acceptable. The MDC data gener-
ated by these tests can be used to monitor meaningful changes in the functional capacity of
the daily living-related activity of CKD patients on HD.
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Introduction
Renal failure is a common problem with more than two million people worldwide were being
treated by dialysis because of chronic kidney disease (CKD) [1]. According to the EPIRCE
(Epidemiology in Chronic Renal Failure in Spain) study, 10% of the Spanish adult population
suffers from some form of renal failure, with 6.8% presenting stage 3–5 CKD; in 2010, this
meant that approximately 4 million people in Spain suffered from CKD requiring renal
replacement treatment [2]. Hemodialysis (HD) is the most common renal replacement
treatment, but other possibilities include peritoneal dialysis or kidney transplantation. The lat-
ter is especially desirable as a definitive treatment, given that patients on long-term HD have
high levels of comorbidity (mainly cardiovascular problems) and physical function problems
[3].
The benefits of exercise for CKD are well described in the literature, and so, since the early
80s, these patients have been prescribed exercise programs as part of their treatment. Physical
function tests are commonly used to assess the effectiveness of exercise and other interven-
tions, and these should be chosen based on their specific reliability in the CKD patient popula-
tion. A previous study investigated the relative and absolute reliability and the minimal
detectable change (MDC) of several physical functional tests, including the sit to stand 10 and
60, one heel rise test, handgrip test, and 6-minute walking test [4], but there are no studies
regarding the reliability of other commonly used tests such as the Short Physical Performance
Battery (SPPB), One-Legged Standing Test (OLST), or Timed Up and Go (TUG) test. Various
authors have reported the functional properties of these tests for several sample groups,
especially in elderly populations, but these tests remain insufficiently studied in CKD groups
[5–18].
The SPPB is a simple test that measures lower extremity function using tasks that mimic
daily activities; it is particularly useful for predicting outcomes such as falls, institutionaliza-
tion, and death in elderly populations [5]. Although this test has been applied to CKD patients
[6,7], neither its relative and absolute reliability nor its MDC have previously been calculated.
The OLST, also known as the one-leg stand [8,9], one-legged stance [10], single leg stance
time [11,12], or unipedal balance test [13], measures the time, in seconds, that a person can
stand on one leg, and is also a good predictor of falls [14]. To the best of our knowledge, no
previous studies have use this test in CKD populations.
Finally, the TUG test is a simple and valid method for assessing patients’ levels of functional
mobility [15]; it measures the time taken for an individual to stand up from a chair, walk three
meters, turn, walk back, and sit back down. The TUG test has been used for different chronic
diseases such as Alzheimer, chronic heart failure, or chronic obstructive pulmonary disease
[16–18]. It has also been used in CKD patients undergoing HD [19–22] but neither its relative
and absolute reliability nor its MDC have been previously calculated.
Aims and hypothesis
The aim of this study was to calculate the test–retest reliability of the SPPB, OLST, and TUG
test and to calculate their absolute reliabilities with the standard error of measurement (SEM)
and MDC scores at the 90% confidence interval (MDC90) threshold.
Materials and methods
Design
This was a prospective, nonexperimental, and descriptive research study.
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Setting and participants
The participants were recruited from two HD units in Valencia and one unit in Barcelona
(Spain) between 2013 and 2015. All the participants were explained the protocol and the pro-
cedures to be used, and signed their written informed consent prior to participation. This
study was approved by the Ethics Committee at the Hospital Universitario Doctor Peset and is
registered at ClinicalTrials.gov (reference number NCT02830490). The attending nephrologist
reviewed and authorized their patients’ potential inclusion before the subjects were
approached to solicit their interest. Patients were included in the study if they had been receiv-
ing maintenance HD for at least 3 months and did not have any acute or chronic medical con-
ditions that would preclude the collection of the test data; they were excluded if they had
recently had a myocardial infarction (within 6 weeks), unstable angina, malignant arrhyth-
mias, or any disorder that was exacerbated by activity. The following demographic and clinical
data were collected from the patients’ medical histories: age, sex, body mass index, time on
HD, creatinine, albumin, and hemoglobin levels, cause of kidney disease, and the Charlson
Comorbidity Index score.
Procedure
Participants performed the SPPB, OLST, and TUG tests twice, with an interval of one to two
weeks between the testing sessions (test–retest evaluation research format), always immedi-
ately before the first HD session of the week. Every effort was made to maintain consistency
between the testing sessions, including control of factors such as the day of the week, time of
day, testing area, and the person conducting the assessment, although not all the subjects
could be assessed in both sessions. At the two HD units in Valencia, two different physical
therapists (researchers 1 and 2) with 11 and 8 years’ experience in physical function evaluation,
respectively, performed and assessed the tests; a renal nurse with 5 years’ experience in evaluat-
ing physical function assessed the participants at the third HD unit in Barcelona.
Short physical performance battery. The SPPB objectively measures lower extremity
function, including performance-based balance, endurance, and strength. Each component is
scored from 0 to 4 and summed to yield scores between 0 (poor) and 12 (best) performance
[5] (Table 1).
To test standing balance, the participants were asked to maintain their feet in the side-by-
side, semi-tandem (heel of one foot beside the big toe of the other foot), and tandem (heel of
one foot directly in front of the other foot) positions for 10 seconds each. In order to test
endurance, we asked the subjects to walk for four meters at their normal pace. Participants
were allowed to use their usual walking aid, although they were encouraged not to use it, and
were scored according to the quartiles for the length of time required. Lower limb strength was
tested by asking the subjects to fold their arms across their chests while standing up and sitting
down five times (STS-5) as quickly as they could. The chair used for the test had no armrests
and was backed up against a wall to minimize the risk falling. A stopwatch recorded the time
taken until the peak of the fifth rise [23,24].
One-legged standing test. The OLST is a good predictor of falls [14]; in elderly cohorts
when the maximum standing time is 30 s with open eyes, the ICC ranges from 0.60 [8] to 0.86
[11], and the MDC95 is 24.1 s [11]; for individuals with a hip fracture in the affected leg the
ICC is 0.75 and the MDC95 is 10.7 s, while in the non-affected leg the ICC is 0.83 and the
MDC95 is 5.5 s [12]; in patients with lower limb amputation the ICC is 0.87 with open eyes and
using a maximum time of 60 s, and the MDC95 is 2.74 s [9].
To perform the OLST patients had to maintain a one-legged stance for as long as they could
with their eyes open, and allowing them to freely-move their arms. All subjects wore shoes and
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they were allowed to choose their preferred leg; if they experienced pain or other symptoms in
the first leg they were permitted to use the other leg. The participants were given three trials to
try to achieve 45 seconds, and they were verbally encouraged to maintain the one-legged
standing position for as long as possible during each trial; the longest balance time from the
three recorded trials was used for the data analysis. The test concluded if the participant used
their arms to touch the wall, if the raised foot touched the ground, if the subject moved the
standing foot, or when 45 seconds had been achieved [13].
Timed up and go test. The TUG test has shown excellent test–retest reliability in older
adults (ICC> 0.98) [15,25], chronic heart failure patients (ICC = 0.93) [16], and those with Par-
kinson (ICC = 0.80) [26] or Alzheimer disease (ICC = 0.985–0.988; MDC90 = 4.09 s) [27]. Here
the TUG test subjects were given verbal instructions to stand up from a standard arm chair (using
the arms if necessary), to walk three meters as quickly and safely as possible, turn back at a cone
set out by the researchers, walk back, and sit down in the chair. The participants were allowed to
wear their regular footwear and to use a walking aid if needed. A stopwatch was started on the
word “go” and stopped when the subject was fully seated with their back against the backrest. The
time to complete the test was recorded in three consecutive trials, using the first one to familiarize
the subjects with the test. The best time from the three trials was analyzed [25,28,29].
Human activity profile. To evaluate the physical activity level, the participants were
asked to complete the Human Activity Profile (HAP) that has been validated in the population
with renal disease [30]. The HAP questionnaire consists of a list of 94 items, which assesses
activities ranked in ascending order of level of energy. The participants had three possibilities
to answer: (1) still doing this activity, (2) have stopped doing this activity, or (3) never did this
activity. The HAP assesses the Maximal activity score level of activity (MAS) (the highest level
of activity) and the adjusted activity score (ASS). The MAS is calculated as the activity with the
highest oxygen consumption requirement that the subject still performs, while the ASS = MAS
Table 1. Short physical performance battery scoring.
Test Scoring Total
Balance
Test
Side by side: the subject is asked to stand with both feet side by side and
the time they can maintain the posture is measured
0! Unable or
0–9 s
1! 10 s
4
points
Semi-tandem: The subject is asked to stand with one foot slightly in front
of the other and the time is they can maintain the posture measured
0! Unable or
0–9 s
1! 10 s
Tandem: The subject is asked to stand with one food in front of the other
and the time they can maintain the posture is measured
0! Unable or
0–2 s
1! 3–9 s
2! 10 s
4-m gait
speed
The time taken for the subject to walk 4 m at their normal pace is
measured twice; the best score from the two trials is used. Use of a walking
aid in the test was recorded.
1! 8.70 s
2! 6.21–8.70
s
3! 4.82–6.20
s
4! 4.82
4
points
STS-5 The time taken for the subject to rise 5 times, as fast as possible, from
sitting in a chair is measured. The test is completed with the patient’s arms
crossed across their chest and they are not allowed to use any tools to help
them to stand. The chair is armless and is situated against a wall in order to
help maintain its stability and to avoid participant falls.
0! 60 s
1! 16.70
2! 13.70–
16.69 s
3! 11.20–
13.69 s
4! 11.19 s
4
points
m: meters; s: seconds; STS: Sit to Stand
https://doi.org/10.1371/journal.pone.0201035.t001
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—number of less demanding activities the subject has stopped performing. The ASS gives us a
better estimate of the range activities performed and of the presence of impairment. Depend-
ing on the AAS, subjects can be classified as impaired activity (AAS less than 53), moderately
active (AAS 53–74) or active (AAS greater than 74) [31]. This questionnaire has been shown to
be test-retest reliability in this population, being the ICC for the MAS = 0.76 (95% confidence
interval = 0.53–0.89) and the MDC95 15.1 points, while for ASS the ICC was = 0.92 (95% confi-
dence interval = 0.83–0.97), being the MDC95 11.4 points [32].
Statistics
Normally-distributed descriptive data are reported as the mean plus the standard deviation
(SD), or otherwise, as the median plus the range. The Kolmogorov–Smirnov test was used to
assess the normality of the data. We also performed paired comparisons with the paired t-test
or the Wilcoxon signed rank test to assess any systematic bias between the trials. The ICC
(model alpha) and a two-way random-effects model were used to assess the test–retest reliabil-
ity of the data for all the repeated tests; we considered an ICC above 0.75 to demonstrate good
reliability, although for clinical measurements it has been suggested that the ICC should
exceed 0.90 [32]. The SEM was used to determine the absolute reliability of the tests and repre-
sents the extent to which the outcome can vary in the measurement process. It was calculated
with the following formula:
SEM ¼ SD
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð1   rÞ
p
Where r is the ICC for the participant groups.
The MDC is defined as the amount of change in a measurement required to conclude that
the difference is not attributable to error; it is the smallest change that falls outside the expected
range of error thus, any change exceeding the MDC90 is considered genuine and indicates con-
fidence in the test’s predictive abilities [4,27,33,34]. The MDC90 was computed from the SEM
with the following formula:
MDC90 ¼ SEM 1:65
ffiffiffi
2
p
A Bland-Altman plot of each participant’s mean score (SPPB, OLST, TUG) plotted against
their difference score (trial 1-trial 2) was constructed to display the spread of difference scores
about the mean difference score. The Bland-Altman plots also display the 95% limits of agree-
ment (95% LOA) which represents the expected range of difference scores across trials of the
tests. The 95% LOA was calculated as the difference in mean scores of the tests ± SD x 1.96,
with the SD as the standard deviation of the difference scores.
Correlation between the three tests and hemoglobin, albumin and creatinine was explored
thouth the Spearman correlation coefficient.
We set the level of significance required to a probability of P 0.05 for all our statistical
analyses. The data were managed and analyzed using the Statistical Package for Social Sciences
(SPSS) version 20.0 for Windows.
Results
Data were collected from 71 participants (29 women and 42 men) with end-stage CKD receiv-
ing HD treatment at three different HD units; the mean age was 61.7±16.4 years. Some demo-
graphic details were unavailable (e.g., no height for one participant); descriptive statistics for
all the participants are shown in Table 2. The activity level of the sample according to the
human activity profile adjusted activity score was low, with a mean score below 53. Fig 1.
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shows the number of subjects who performed each test; there were 6, 9, and 5 drop outs for the
SPPB, OLST, and TUG test, respectively, and the reasons for these withdrawals are shown in
Fig 1; no adverse events occurred during testing.
The results of the repeated tests are shown in Table 3 (see S1 Table Original data from
SPPB, S2 Table Original data from OLST, S3 Table Original data from TUG). For the SPPB,
the mean plus SD in trial 1 and trial 2 were 9.6±3 and 10±2.9 repetitions, respectively
(p = 0.94); for the OLST it was 13.5±14.9 s for trial 1 and 15.1±15 s for trial 2 (p = 0.89); and for
the TUG test it was 11.2±6.3 s and 10.7±5.8 s for trial 1 and 2, respectively (p = 0.96). The ICCs
were high for all of the outcome measurements: 0.94 (95% confidence interval [CI] = 0.91–
0.97) for the SPPB; 0.90 (95% CI = 0.83–0.94) for the OLST, and 0.96 (95% CI = 0.94–0.98) for
the TUG test. The paired comparisons showed insignificant differences between trial 1 and
trial 2 for all three tests. Table 4 shows the MDC90 values for the SPPB, OLST, and TUG test
(1.7 points, 11.3 s, and 2.9 s, respectively).
Bland-Altman plots indicated no systematic bias as scores were distributed above and
below the mean difference (Fig 2, Fig 3 and Fig 4).
Spearman correlation coefficient showed a significant correlation only between the TUG
and the inverse creatinine value (r = 0.375; p = 0.004)
Discussion
The SPPB, OLST, and TUG test are widely used performance tests, probably owing to their
simplicity and low cost. Our findings demonstrated that the test–retest relative reliability
(ICC) for the use of these clinical tests for CKD patients was excellent: all three values reached
or exceeded 0.90±33, meaning that the two successive assessments we performed one to two
weeks apart were very reproducible.
Table 2. Demographic and clinical data for the participants in the test–retest reliability and minimal detectable
change study (N = 71).
Characteristic Value
Age, mean (SD) 61.7 (16.4)
Sex (women:men) 29:42
Body Mass Index (kg/m2), mean (SD) 25.87 (6.23)
Time on hemodialysis (median in months; P25–P75) 56 months
34–96 months
Creatinine levels (mg/dL), mean (SD) 9.23 (3.04)
Hemoglobin levels (g/dL), mean (SD) 11.00 (1.37)
Albumin levels (g/dL), mean (SD) 4.18 (4.52)
Cause of Kidney Disease (number of participants)
• DiabetesMellitus 14
• Glomerulonephritis 13
• Nephroangiosclerosis 6
• Lupus 3
• Pyelonephritis 5
• Polycystic kidney disease 3
• High Blood Pressure 4
• Others 23
Charlson Comorbidity Index, mean (SD) 6.73 (2.43)
Physical Activity Level (Human Activity Profile–Adjusted Activity Score), mean (SD) 38.6 (32.0)
SD: standard deviation
https://doi.org/10.1371/journal.pone.0201035.t002
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Test–retest reliability
The SPPB examines three areas of lower-extremity function (static balance, gait speed, and get-
ting in and out of a chair) that are representative of essential tasks for independent living
among CKD patients on HD. The SPPB is useful for predicting outcomes such as falls, institu-
tionalization, and death in elderly population [5], and although it has previously been applied
Fig 1. Flow chart for study participants in the test—retest reliability and minimal detectable change for the SPPB,
the OLST and TUG HD: Hemodialysis; OLST: One-Legged Standing Test; SPPB: Short Physical Performance
Battery; TUG: Timed Up and Go test.
https://doi.org/10.1371/journal.pone.0201035.g001
Table 3. Reliability results for the SPPB, OLST, and TUG physical performance tests in patients undergoing hemodialysis.
Test No. of
participants
Trial 1 Trial 2 ICC for trial 1 vs.
trial 2
95% CI for
ICC
P of a significant difference between trial 1 and
trial 2
Median (Min-
Max)
Median (Min-
Max)
SPPB
(points)
65 11 (0–12) 11(0–12) 0.94 0.91–0.97 0.942
OLST
(seconds)
62 4.4 (0–45) 8.1 (0–45) 0.90 0.83–0.94 0.895
TUG test
(seconds)
66 9.0 (4.60–37.5) 8.6 (3.72–32.5) 0.96 0.94–0.98 0.962
ICC: intraclass correlation coefficient; CI: confidence interval; OLST: One-Legged Standing Test; SPPB: Short Physical Performance Test; TUG: Timed Up and Go
https://doi.org/10.1371/journal.pone.0201035.t003
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Table 4. Standard error of measurement for repeated measures and minimal detectable change scores at a 90%
confidence interval (MDC90) for the SPPB, OLST, and TUG test.
Test MDC90 CI 95% SEM CI 95%
SPPB
(points)
1.7 1.3–2.1 0.72 0.56–0.91
OLST
(seconds)
11.3 8.9–14.2 4.82 3.80–6.10
TUG
(seconds)
2.9 2.2–3.7 1.24 0.96–3.66
CI: confidence interval; OLST: One-Legged Standing Test; SPPB: Short Physical Performance Battery; TUG: Timed
Up and Go test; SEM: standard error of measurement.
https://doi.org/10.1371/journal.pone.0201035.t004
Fig 2. Bland-Altman plot showing levels of agreement for the test-retest data for the SPPB. SPPB: Short Physical Performance Battery.
https://doi.org/10.1371/journal.pone.0201035.g002
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to HD patients [6,35], to our knowledge, ours is the first study describing the relative reliability
of the SPPB in patients undergoing HD. Our results showed that this test has excellent test–
retest reliability (ICC = 0.94; 95% CI = 0.91–0.97), and are consistent with values reported for
a community-dwelling older population (ICC = 0.82; n = 487; mean age 74.1±5.7 years) [36]
and for older women (ICC = 0.88–0.92; n = 1002; mean age 78.3±0.3 years) [37].
Similar to our study, Studenski et al. [36] performed the test–retest after one week, although
they used a different testing site between trials: first during an outpatient clinic visit and then
as part of a comprehensive home visit. In our case, we acquired all the measurements for both
trails at the same location and within one or two weeks. In our study the ICC for the SPPB was
high, suggesting that it is a good physical performance test for identifying loss of mobility in
CKD patients undergoing HD. Future longitudinal studies should clarify whether the SPPB
can predict difficulties in the activities of daily living in HD patients, as it can in elderly and
older hospitalized patient populations [37,38].
Fig 3. Bland-Altman plot showing levels of agreement for the test-retest data for the OLST. OLST: One-Legged Standing Test.
https://doi.org/10.1371/journal.pone.0201035.g003
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No previous studies have reported the relative reliability for the OLST in patients undergo-
ing HD, although the OLST ICC values reported in other populations are generally lower than
our results (ICC0.90). In elderly populations the ICC ranges from 0.60 [8] to 0.86 [11], fol-
lowing hip fracture it was 0.75 and 0.83 in the affected and non-affected leg, respectively [12],
and it was 0.87 for patients with a lower-limb amputation [9]. In contrast, an ICC of 0.994 was
reported for a subgroup of 50 healthy military health-care beneficiaries aged 18 and older.
There are a wide variety of published protocols for performing the OLST, but surprisingly
little consensus regarding how it should be conducted. For example, some studies use a maxi-
mum time of 10 seconds [39,40], and others 30 seconds [8,12,41], 45 seconds [13,39], or 60
seconds [9,11,42]. We chose to use 45 seconds as maximum time because Briggs et al. [10]
posit that a limit of 45 seconds results in normal data distribution [10,13]. Another variable is
the number of attempts the patient is allowed to achieve the maximum time: while some
Fig 4. Bland-Altman plot showing levels of agreement for the test-retest data for the TUG. TUG: Timed Up and Go test.
https://doi.org/10.1371/journal.pone.0201035.g004
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studies do not report this factor [8,12], in other trials it ranges between three [39,41,42] and
five [9,11]. Additionally, some authors use the average of the trials for their statistical analyses
[11,39] while others use the single longest time achieved [9,10,42]. Following the procedure
published by Hurvitz et al. [13], itself based on Briggs et al. [10], we performed three trials and
used the longest time achieved for our data analysis. This strategy appears to provide a good
indication of balance capabilities because the best trial results were almost always obtained
among the first three test trial results [10,13].
The details of how the OLST studies are executed also often differ: as in other studies we
allowed our participants to keep their eyes open [9,39,41,42], wear shoes, choose the leg they
preferred for the test, and to move their arms to help maintain their balance [13]. Moreover,
our sample size was larger than that of previous studies (n = 62) and the ages included ranged
from 21 to 90 years (mean 61.4±16.4 years), making ours a relatively young sample compared
to other studies (see Table 5). Future studies should aim to assess if the OLST is useful for pre-
dicting falls in CKD patients.
The TUG test is a validated and commonly used method for assessing functional mobility;
its relative reliability values have been reported in different populations including elderly
(ICC = 0.98–0.99) [15,25], chronic heart failure (ICC = 0.93) [16], Parkinson disease
(ICC = 0.80) [26], and Alzheimer disease (ICC = 0.985–0.988) [27] cohorts. Our results
showed that the relative reliability of this test for patients undergoing HD is excellent
(ICC = 0.96), therefore suggesting that this is an appropriate test for assessing this aspect of
physical function in CKD patient groups. Additionally, this was the only test that correlated
with the inverse creatinine values of the sample.
Taken together, our findings demonstrate that test–retest reliability for the SPPB, OLST,
and TUG clinical tests was excellent. Factors that might explain these good results, and that
should therefore be considered in the application these tests in clinical environments, include
performing these tests (i) before a HD session, (ii) on the same day of the week, and (iii) after
adequate research training and standardization of the assessors’ instructions. However, it is
surprising that the relative reliability (ICC) in a sample with such high comorbidity (CKD
patients on maintenance HD) was higher than in other cohorts with, presumably, lower health
status variability (e.g. elderly populations with no chronic disease). This could mean that
young people receiving renal replacement treatment are usually in a better physical condition
than elderly populations receiving HD, leading to the increased consistency seen in the former
in this present study.
Another reason could be the uniformity of our protocol which we designed to ensure stan-
dardization, both of the procedures and between the researchers performing the tests. Our
testing instructions were the result of a consensus between the different research teams at each
Table 5. Characteristics of selected studies which use the one-legged standing test.
Author Type of population N Range age
min-max
Mean age (SD)
Wolinsky et al. [8] Elderly African Americans 53 50–64 56.6
Sherrington & Lord [12] Hip fracture 30 62–95 79.8 (10.0)
Goldberg et al. [11] Older community-dwelling individuals 25 60–89 72.0 (9.1)
Kristensen et al. [9] Lower-limb amputation 36 67.4 (10.6)
Giorgetti et al. [42] Non-disabled community 21 69–85 73.1
Older people with some physical disability 21 61–89 75
Chomiack et al. [43] Parkinson disease 27 67.1 (10.2)
SD: standard deviation
https://doi.org/10.1371/journal.pone.0201035.t005
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center undertaking the study. Surprisingly, our review of previously published studies regard-
ing functional testing, revealed inconsistencies between the testing protocols used across a
variety of tests, including the OLST. These factors might lead to inappropriate results being
reported and may hinder meaningful comparison between the outcomes of different studies.
Thus, we believe it is very important that both researchers and clinicians assess physical func-
tioning in future studies using the same tools and by implementing standardized instructions.
Minimal detectable change
Despite the excellent test–retest reliability results for our patient cohort, the performance of
individual participants between sessions still substantially varied, producing high MDC values
(Table 4). The MDC90 is the threshold of change that a measurement must reach in order to
exceed the anticipated measurement error and variability, and is a conservative estimate of
clinically meaningful score changes. In this case, the magnitude of clinically meaningful
change in these physical performance tests can help clinicians and researchers to identify
important functional changes in CKD patients undergoing HD [4]. The MDC for the SPPB,
OLST, and TUG test have been previously studied in other populations including the elderly
[5,8,11,43], people recovering from a hip fracture [12] or lower-limb amputation [9], and in
groups with Alzheimer disease [27]. Nevertheless, to our knowledge, this is the first study to
calculate the MDC of these tests in patients with CKD undergoing HD.
Our results produced an MDC90 of 1.7 points for the SPPB, whereas in an elderly popula-
tion, a change of one point was representative of a meaningful difference in the risk of future
mortality and the incidence of disability [5]. Another large study of older adults (n = 482;
mean age 74.1±5.7 years) reported a SEM of 1.42 points [44], compared to the SEM of 0.72
points we obtained in this study. In this case, the time frame of the test–retest assessment was
longer than in our study: the subjects were evaluated at the participant’s house every three
months for the first year and every 6 months for the second year. In our study we strictly repli-
cated all the measurement conditions, but even so, the physiological and clinical status of
patients undergoing HD can widely vary, potentially leading to heterogeneity in the results.
Our OLST results gave an MDC90 of 11.3 s, whereas in a community-dwelling population,
the MDC95 was 24.1 s [11]. This, perhaps surprising difference can be explained by the high SD
in the latter study sample (20.4 s) [45]. In patients with a lower-limb amputation the MDC95
was 2.74 s [9], and this difference can also be related to the evaluation procedure: while we per-
formed three trials with a maximum time of 45 seconds, other studies performed five trials with
a maximum time of 60 seconds [9,11]. We chose three rather than five trials to try to achieve
the longest time possible (in the knowledge that the best score is usually obtained in the first
three trials), while also aiming to reduce variability and to avoid muscle fatigue [10].
The MDC90 for the TUG test in this present study was 2.9 s. In comparison, the MDC95 in a
cohort with Parkinson disease was 3.5 s [26] (similar to our results if we calculate the MDC90)
and in another sample with Alzheimer disease, the MDC90 was 4.09 s [27]. The high MDC
found in the Alzheimer disease study can be explained by its high SD (19.95 ± 9.81 s in mild-
moderate disease and 28.01 ± 17.49 s in moderate-severe to severe disease); patients with a
higher level of dementia produce more variable results and need more time to perform the test
compared to less demented subjects, thus generating higher MDC scores. Another important
difference is the number of trials performed: while we carried out three trials, Ries at al. [27]
performed two trials in patients with Alzheimer disease and Huang et al. [26] only measured
the TUG once, so as to avoid fatigue (although they concluded that more trials would increase
the stability of the measurement and would reduce its MDC). Hence, performing more than
one trial increases the stability of the test, and as a result, decreases the MDC.
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In summary, the MDC90 results that we obtained in this study (1.7 points for the SPPB, 11.3
s for the OLST, and 2.9 s for the TUG test) represent the threshold-change values required to
be 90% certain that any changes noted in the test results for any given individual patient are
not due to internal variability. In the clinical field, researchers and clinicians should use these
MDC values to determine whether differences in the test results obtained between follow-up
trails in their CKD patients on maintenance HD represent true changes which may be associ-
ated with poor prognosis.
Study limitations
The main limitation of this study was the variability of our cohort in terms of its broad sample
age range which may have introduced error related to the probable increased presence of
comorbidities in older patients. It is also worth noting that the patient participation rate was
low. Additionally, we did not register interdialytic weight gain between the first and the second
evaluation day, though we tried to keep all other factors stable (HD session of the week, time,
assessor). Moreover, only 30 minutes were available to perform these assessment tests before
the HD session started which may have led us to rush in some cases. However, despite this
time constraint, we tried to limit extrinsic variation by following a strict methodology. Another
potential limitation to inter-study comparisons is the lack of academic consensus on the exact
OLST testing procedure.
Conclusions
In conclusion, our results demonstrate excellent test–retest reliability for the SPPB, the OLST,
and the TUG test in CKD patients undergoing HD. The MDC90 values for each test provide
clinicians with useful threshold values for identifying true changes beyond those that can be
expected from individual variability. This information will help care givers to monitor changes
in the performance of their patients over time and to assess the effectiveness of interventions
to maintain or improve the physical performance of patients receiving HD treatment.
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